Abstract:Background Obesity is a major risk factor for dysglycemic disorders, including type 2 diabetes (T2D). However, there is wide phenotypic variation in metabolic profiles. Tissue-specific epigenetic modifications could be partially accountable for the observed phenotypic variability. Scope The aim of this systematic review was to summarize the available data on epigenetic signatures in human adipose tissue (AT) that characterize overweight or obesity-related insulin resistance (IR) and dysglycemia states and to identify potential underlying mechanisms through the use of unbiased bioinformatics approaches. Methods Original data published in the last decade concerning the comparison of epigenetic marks in human AT of individuals with metabolically unhealthy overweight/obesity (MUHO) versus normal weight individuals or individuals with metabolically healthy overweight/obesity (MHO) was assessed. Furthermore, association of these epigenetic marks with IR/dysglycemic traits, including T2D, was compiled. Results We catalogued more than two thousand differentially methylated regions (DMRs; above the cut-off of 5%) in the AT of individuals with MUHO compared to individuals with MHO. These DNA methylation changes were less likely to occur around the promoter regions and were enriched at loci implicated in intracellular signaling (signal transduction mediated by small GTPases, ERK1/2 signaling and intracellular trafficking). We also identified a network of seven transcription factors that may play an important role in targeting DNA methylation changes to specific genes in the AT of subjects with MUHO, contributing to the pathogeny of obesity-related IR/T2D. Furthermore, we found differentially methylated CpG sites at 8 genes that were present in AT and whole blood, suggesting that DMRs in whole blood could be potentially used as accessible biomarkers of MUHO. Conclusions The overall evidence linking epigenetic alterations in key tissues such AT to metabolic complications in human obesity is still very limited, highlighting the need for further studies, particularly those focusing on epigenetic marks other than DNA methylation. Our initial analysis suggests that DNA methylation patterns can potentially discriminate between MUHO from MHO and provide new clues into why some people with obesity are less susceptible to dysglycemia. Identifying AT-specific epigenetic targets could also lead to novel approaches to modify the progression of individuals with obesity towards metabolic disease. Systematic Review Registration PROSPERO , identifier CRD42021227237.

Epigenetics in Obesity and Diabetes Mellitus: New Insights

Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes

Epigenetic Modifications in Obesity-Associated Diseases

Update: the role of epigenetics in the metabolic memory of diabetic complications

Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes

Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?

The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes

Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications

Epigenetics and Obesity Cardiomyopathy: from Pathophysiology to Prevention and Management.

Epigenetic Mechanisms in Obesity: Broadening Our Understanding of the Disease

DNA methylation and gene expression analysis in adipose tissue to identify new loci associated with T2D development in obesity

Adipose Tissue Epigenetic Profile in Obesity-Related Dysglycemia - A Systematic Review

Early-life Programming of Type 2 Diabetes Mellitus: Understanding the Association between Epigenetics/Genetics and Environmental Factors

A Recent Update on the Epigenetic Repertoire and Chromatin Modifying Therapy in Diabetes Mellitus: A Comprehensive Review

The role of epigenetic modifications in the formation of heterogeneous phenotypes in diabetes mellitus (a literature review)

Recent progress in epigenetics of obesity

Diabetes Mellitus and Pregnancy: An Insight into the Effects on the Epigenome

Epigenetic,diabetes and Its Complications

DNA or histone epigenetics modification and obesity or diabetes:mechanism and inhibitors

Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.

Epigenetic regulation of white adipose tissue in the onset of obesity and metabolic diseases